Pramipexole

Mirapex

Ancillary aas Oral FDA/EMA Label

Half-life

10 hr

Time to Peak

2 hr

Steady State

~3 days

Bioavailability

90%

Dose Range

0.125–0.5 mg

Frequency

Daily

Overview

Dopamine agonist used as an alternative to cabergoline for prolactin management. Shorter half-life means more frequent dosing but faster washout if side effects occur.

Mechanism of Action

Non-ergot dopamine D2/D3 receptor agonist. Suppresses prolactin via direct dopaminergic stimulation of the pituitary.

Dosing Information

Route Dose Range Half-life Tmax Frequency
Oral 0.125–0.5 mg 10 hr 2 hr Daily

Used in Regimens

Pramipexole is not currently part of any catalog regimen.

Data Sources

Related Tools

Track Pramipexole with Doseline

Reminders, medication level charts, injection site rotation, and protocol tracking — all free, all private.

Join the waitlist

Doseline provides informational tools only. It is not a medical device and does not provide medical advice. Always consult a qualified healthcare provider.

Doseline provides informational tools only. It is not a medical device and does not provide medical advice. Always consult a qualified healthcare provider.